Genedrive to present data for its Hepatitis-C test at International Liver Conference
Data will be presented to a host of industry professionals at the event in Amsterdam
Company
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
240 stories · page 12 of 12
Data will be presented to a host of industry professionals at the event in Amsterdam
Investments and investor services
US markets open lower, but the index of blue-chip shares keeps its poise
Genedrive’s HCV assay provides on-the-spot results in just 90 minutes direct from a very small plasma sample.
Regulatory sign-off fires starting pistol on the commercial launch in Europe, Africa, EU Medical Devices Directive awarded CE IVD certification, molecular diagnostics, Europe, Africa, Sysmex
Archive
A glance at some of the stories on the Proactive newswire today
Main share price rises and falls at 3.30pm: Jersey Oil and Gas, Beowulf Mining
The receipt of CE IVD certification under the EU Medical Devices Directive would green-light the commercialisation of the product in the European Union.
The studies were performed at Queen's Medical Centre and Institut Pasteur
Archive
Condor Gold reports drilling results from La India; Genedrive making "good progress" in realising potential of breakthrough device; Porta settles Grand Retro debt; and more…
Chief executive David Budd said: "We are making good progress towards realising the proven potential of the Genedrive platform in a range of applications through our own programmes and partnerships.”
Archive
Hurricane Energy kicks off the Halifax well; MySQUAR user base smashes through the 7.5mln mark; Orosur Mining sees big uptick in profits and cash inflow; plus more…
Officials will assess the technology's potential to check for hazards such as biological warfare agents.
It has been awarded what’s called CE-IVD certification, that’s the official CE mark for an in-vitro diagnostic medical device.
The year has seen us take further significant strides towards realising the potential of the Genedrive platform to bring the strength of hospital-based, central laboratory diagnostics close to the point of need and near patient setting - ch
CloudTag raises £580,000, Solo Oil unveils a series of board changes and IronRidge confirms ‘very advanced’ discussions were underway over an investment in a gold prospect in Chad.
The STOP-HCV-1 clinical trial will assess two direct acting anti-viral (DAA) treatment combinations and whether the addition of another, older drug has value in short course treatment
Versarien funds a push into graphene-related technologies, Epistem Holdings has been renamed Genedrive and Amur Minerals PLC updates on progress at the giant Kun-Manie nickel project in Russia.